Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
salvia
- Development stage
- Phase 1
- Lead developer
- Xiyuan Hospital
- Modality
- Small Molecules
- Administration
- Oral, Topical
01
Overview
Salvia refers to a genus of plants, with various species traditionally used for medicinal purposes. Preparations derived from Salvia species are currently under investigation for their therapeutic potential. Clinical trials are exploring its efficacy and safety in conditions such as sepsis with gastrointestinal dysfunction, where it is used as an external treatment, and for postoperative angina pectoris, where it is formulated into tablets for oral administration. While specific molecular mechanisms are not detailed, its use in these conditions suggests potential anti-inflammatory, antimicrobial, or cardiovascular effects.
02
Targets
KOR (Kappa opioid receptor)
Beyond the preview
Go deeper on salvia.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on salvia.